Correction: A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas.

Adams, Olivia JoanOlivia JoanAdamsJanser, Ariane FéliceAriane FéliceJanserDislich, BastianBastianDislich0000-0002-4838-4686Berezowska, Sabina AnnaSabina AnnaBerezowska0000-0001-5442-9791Humbert, MagaliMagaliHumbert0000-0003-3820-0297Seiler, Christian A.Christian A.SeilerKröll, DinoDinoKröllSlotta-Huspenina, JuliaJuliaSlotta-HuspeninaFeith, MarcusMarcusFeithOtt, KatjaKatjaOttTschan, MarioMarioTschan0000-0001-5897-3647Langer, RupertRupertLanger0000-0001-9491-36092024-10-282024-10-282019-10https://boris-portal.unibe.ch/handle/20.500.12422/186428[This corrects the article DOI: 10.1371/journal.pone.0197610.].en500 - Science::570 - Life sciences; biology600 - Technology::610 - Medicine & healthCorrection: A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas.article10.7892/boris.1394453166519310.1371/journal.pone.0224832